\-\ Texto\\:\\ \ \(0\)\
\-\ left\\ sensorineural\\ hearing\\ loss\\.\ \(1\)\
\-\ patient\\ underwent\\ resection\\ of\\ the\\ left\\ cpa\\ epidermoid\\ mass\\.\\ \\ serial\\ mri\\ brain\\ exams\\ performed\\ to\\ follow\\ up\\.\ \(0\)\
\-\ with\\ respect\\ to\\ csf\\ on\\ t1\\ and\\ t2wi\\,\\ there\\ is\\ a\\ hyperintense\\ mass\\ in\\ the\\ left\\ cerebellopontine\\ angle\\.\\ this\\ mass\\ measured\\ 4\\.1\\ cm\\ transverse\\ x\\ 2\\.6\\ ap\\ x\\ 3\\.7\\ cm\\ superior\\/inferior\\.\ \(0\)\
\-\ epidermoid\\ brain\\ tumor\ \(0\)\
\-\ arachnoid\\ cyst\\ vs\\.\\ epidermoid\ \(0\)\
\-\ 48\\ y\\/o\\ male\\ who\\ presented\\ for\\ mri\\ iac\\ after\\ being\\ diagnosed\\ with\\ left\\ sided\\ sensorineural\\ hearing\\ loss\\.\ \(0\)\
\-\ for\\ this\\ patient\\,\\ the\\ epidermoid\\ caused\\ mass\\ effect\\ on\\ the\\ pons\\ and\\ insinuated\\ itself\\ between\\ some\\ of\\ the\\ crainal\\ nerves\\.\\ \\ this\\ likely\\ played\\ a\\ role\\ in\\ the\\ \\ patient\\'s\\ sensorineural\\ hearing\\ loss\\.\\ \\ \ \(0\)\
\-\ arachnoid\\ cysts\\ tend\\ to\\ follow\\ csf\\ imaging\\ characteristics\\ very\\ closely\\ whereas\\ epidermoids\\ can\\ be\\ more\\ heterogenous\\.\\ \\ epidermoids\\,\\ as\\ well\\ as\\ arachnoid\\ cysts\\ occur\\ commonly\\ in\\ the\\ cpa\\.\\ \ \(0\)\
\-\ patients\\ with\\ cpa\\ epidermoid\\ inclusion\\ cysts\\ often\\ present\\ with\\ facial\\ pain\\,\\ rather\\ than\\ hearing\\ loss\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ epidermoid\\:\\ 0\\.12260802095190507\ \(0\)\
\-\ sensorineural\\:\\ 0\\.10811394722729425\ \(0\)\
\-\ cpa\\:\\ 0\\.10811394722729425\ \(0\)\
\-\ hearing\\:\\ 0\\.10145417440911823\ \(0\)\
\-\ epidermoids\\:\\ 0\\.08682024712689636\ \(0\)\
\-\ arachnoid\\:\\ 0\\.07759752735392995\ \(0\)\
\-\ cysts\\:\\ 0\\.06049623402707289\ \(0\)\
\-\ loss\\:\\ 0\\.059770221023335894\ \(0\)\
\-\ superior\\/inferior\\:\\ 0\\.04892994724943707\ \(0\)\
\-\ insinuated\\:\\ 0\\.04892994724943707\ \(0\)\
\-\ crainal\\:\\ 0\\.04648738635721921\ \(0\)\
\-\ played\\:\\ 0\\.044754361824377156\ \(0\)\
\-\ csf\\:\\ 0\\.04299390785308448\ \(0\)\
\-\ 3\\.7\\:\\ 0\\.03640319097425733\ \(0\)\
\-\ iac\\:\\ 0\\.03640319097425733\ \(0\)\
\-\ 4\\.1\\:\\ 0\\.03505895271332836\ \(0\)\
\-\ x\\:\\ 0\\.03396465464274069\ \(0\)\
\-\ 2\\.6\\:\\ 0\\.03396063008203947\ \(0\)\
\-\ respect\\:\\ 0\\.03282061803602424\ \(0\)\
\-\ follow\\:\\ 0\\.03271324664995704\ \(0\)\
\-\ cerebellopontine\\:\\ 0\\.0326163918211105\ \(0\)\
\-\ inclusion\\:\\ 0\\.03168777326793425\ \(0\)\
\-\ closely\\:\\ 0\\.03103588420383646\ \(0\)\
\-\ brain\\:\\ 0\\.030980138834973036\ \(0\)\
\-\ t2wi\\:\\ 0\\.030883367288268446\ \(0\)\
\-\ whereas\\:\\ 0\\.03058945063664536\ \(0\)\
\-\ role\\:\\ 0\\.0304477006522466\ \(0\)\
\-\ pons\\:\\ 0\\.029419836091820317\ \(0\)\
\-\ tend\\:\\ 0\\.029188111508520343\ \(0\)\
\-\ exams\\:\\ 0\\.02907550829760376\ \(0\)\
\-\ itself\\:\\ 0\\.028964971317674865\ \(0\)\
\-\ mass\\:\\ 0\\.02863761462524252\ \(0\)\
\-\ measured\\:\\ 0\\.027958621410065426\ \(0\)\
\-\ cm\\:\\ 0\\.02761392913032513\ \(0\)\
\-\ heterogenous\\:\\ 0\\.02641386521158545\ \(0\)\
\-\ nerves\\:\\ 0\\.026133624153543925\ \(0\)\
\-\ serial\\:\\ 0\\.025672539351602155\ \(0\)\
\-\ characteristics\\:\\ 0\\.025609459231919655\ \(0\)\
\-\ 48\\:\\ 0\\.025185478528535317\ \(0\)\
\-\ rather\\:\\ 0\\.024469447185904422\ \(0\)\
\-\ angle\\:\\ 0\\.024165646862850856\ \(0\)\
\-\ mri\\:\\ 0\\.023653925962826748\ \(0\)\
\-\ left\\:\\ 0\\.02303868118729915\ \(0\)\
\-\ facial\\:\\ 0\\.022383445759893372\ \(0\)\
\-\ caused\\:\\ 0\\.02159283016332477\ \(0\)\
\-\ hyperintense\\:\\ 0\\.02137144737893476\ \(0\)\
\-\ transverse\\:\\ 0\\.020641245145481914\ \(0\)\
\-\ vs\\:\\ 0\\.02026795162892047\ \(0\)\
\-\ commonly\\:\\ 0\\.0194248882135882\ \(0\)\
\-\ occur\\:\\ 0\\.019313533908322522\ \(0\)\
\-\ sided\\:\\ 0\\.019033292850281\ \(0\)\
\-\ diagnosed\\:\\ 0\\.018928886486716902\ \(0\)\
\-\ ap\\:\\ 0\\.018826258853267698\ \(0\)\
\-\ very\\:\\ 0\\.018685455532874273\ \(0\)\
\-\ effect\\:\\ 0\\.018226254536561716\ \(0\)\
\-\ being\\:\\ 0\\.017938481787955173\ \(0\)\
\-\ underwent\\:\\ 0\\.01766383153902542\ \(0\)\
\-\ this\\:\\ 0\\.017369949638207222\ \(0\)\
\-\ often\\:\\ 0\\.016424539448913568\ \(0\)\
\-\ t1\\:\\ 0\\.016316238170025567\ \(0\)\
\-\ between\\:\\ 0\\.016316238170025567\ \(0\)\
\-\ resection\\:\\ 0\\.016053708768194088\ \(0\)\
\-\ some\\:\\ 0\\.015632097914859994\ \(0\)\
\-\ as\\:\\ 0\\.015573222962579854\ \(0\)\
\-\ patient\\:\\ 0\\.015480577064753998\ \(0\)\
\-\ likely\\:\\ 0\\.014519819071901545\ \(0\)\
\-\ performed\\:\\ 0\\.014352881513417586\ \(0\)\
\-\ y\\/o\\:\\ 0\\.014256801384455666\ \(0\)\
\-\ presented\\:\\ 0\\.01403227490977355\ \(0\)\
\-\ up\\:\\ 0\\.013842452717194116\ \(0\)\
\-\ cyst\\:\\ 0\\.013833561060398208\ \(0\)\
\-\ than\\:\\ 0\\.013488246113965506\ \(0\)\
\-\ who\\:\\ 0\\.013421496440612664\ \(0\)\
\-\ patients\\:\\ 0\\.013322738550397747\ \(0\)\
\-\ more\\:\\ 0\\.012874556080193774\ \(0\)\
\-\ imaging\\:\\ 0\\.012060685689491583\ \(0\)\
\-\ tumor\\:\\ 0\\.012001399407294043\ \(0\)\
\-\ can\\:\\ 0\\.011676038267885961\ \(0\)\
\-\ well\\:\\ 0\\.011645065981738862\ \(0\)\
\-\ present\\:\\ 0\\.011626558758624584\ \(0\)\
\-\ \\'s\\:\\ 0\\.011349678423897861\ \(0\)\
\-\ after\\:\\ 0\\.010650609654272305\ \(0\)\
\-\ male\\:\\ 0\\.00930846709570767\ \(0\)\
\-\ for\\:\\ 0\\.008784435525815846\ \(0\)\
\-\ on\\:\\ 0\\.008721578462234073\ \(0\)\
\-\ be\\:\\ 0\\.007938293514120055\ \(0\)\
\-\ to\\:\\ 0\\.007718098345355173\ \(0\)\
\-\ there\\:\\ 0\\.007660937087138486\ \(0\)\
\-\ in\\:\\ 0\\.007615612592896173\ \(0\)\
\-\ \\,\\:\\ 0\\.0065231341088502984\ \(0\)\
\-\ pain\\:\\ 0\\.006286796189944185\ \(0\)\
\-\ the\\:\\ 0\\.005829789114008316\ \(0\)\
\-\ a\\:\\ 0\\.004778310865284353\ \(0\)\
\-\ is\\:\\ 0\\.0033872938456911183\ \(0\)\
\-\ with\\:\\ 0\\.002819377737105777\ \(0\)\
\-\ \\.\\:\\ 0\\.002566231525109369\ \(0\)\
\-\ and\\:\\ 0\\.0021687832015929937\ \(0\)\
\-\ of\\:\\ 0\\.001403660250578174\ \(0\)\
